BRTXBioRestorative Therapies, Inc.

Nasdaq biorestorative.com


$ 1.42 $ 0.02 (1.43 %)    

Thursday, 15-Aug-2024 11:40:49 EDT
QQQ $ 474.17 $ 3.42 (0.73 %)
DIA $ 405.29 $ 1.90 (0.47 %)
SPY $ 552.55 $ 3.14 (0.57 %)
TLT $ 96.82 $ 0.26 (0.27 %)
GLD $ 226.85 $ 0.88 (0.39 %)
$ 1.4
$ 1.42
$ 1.43 x 100
-- x --
$ 1.42 - $ 1.42
$ 1.03 - $ 3.67
27,510
na
11.37M
$ 4,906.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 06-11-2024 03-31-2024 10-Q
3 03-29-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-27-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-13-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 04-30-2021 12-31-2020 10-K
16 04-12-2021 06-30-2020 10-Q
17 04-12-2021 09-30-2020 10-Q
18 03-29-2021 03-31-2020 10-Q
19 03-18-2021 12-31-2019 10-K
20 11-13-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-22-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-13-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-23-2015 09-30-2015 10-Q
37 08-14-2015 06-30-2015 10-Q
38 05-15-2015 03-31-2015 10-Q
39 03-31-2015 12-31-2014 10-K
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 roth-mkm-maintains-buy-on-biorestorative-therapies-raises-price-target-to-18

Roth MKM analyst Jonathan Aschoff maintains BioRestorative Therapies (NASDAQ:BRTX) with a Buy and raises the price target fr...

 biorestorative-therapies-q2-2024-gaap-eps-050-beats-055-estimate

BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate...

 whats-going-on-with-biorestorative-therapies-stock

BioRestorative Therapies shares are trading higher Monday after the company announced it has received notice from the Nasdaq St...

 why-biorestorative-therapies-stock-is-moving-higher-thursday

BioRestorative Therapies announced before the market opened on Thursday that it engaged in substantive licensing discussions wi...

 biorestorative-therapies-engages-in-advanced-discussions-for-thermostem-license-with-a-regenerative-medicine-firm

- Brown adipose derived stem cells with brown adipogenic potential would represent a new modality for the treatment of obesity ...

Core News & Articles
Market-Moving news for April 16th
04/16/2024 12:36:44

CGEM: 23% | Cullinan Therapeutics To Pursue Development Of CLN-978 In Autoimmune Diseases, With Systemic Lupus Erythematosus As...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION